Calmark Neo-Bilirubin receives UNICEF’s quality seal "NEST360 Qualified"
Calmark Sweden AB announced today that the company's diagnostics for jaundice, Neo-Bilirubin, meets the characteristics for products in low-income countries, developed by the organization NEST360 in collaboration with UNICEF. The award shows that Calmark's product is efficient, affordable, robust and easy to use.Newborn Essential Solutions and Technologies (NEST360) is an international alliance of clinical, technical, and public health experts from 16 leading institutions, governments, and organizations. NEST360s is financed through support from e.g. Bill & Melinda Gates Foundation, CIFF,